- World rank, all time
- #36,419 of 42,892
- Rank in China
- #3,277 of 3,536
- Research works
- 534 ▼ 62% vs 2013–17
- Citations
- 2.1k 3.9 per fractional work
- Top-10% rate
- 13.4% record average 16.5%
- Open access
- 14% world 28%
What is The Fifth People's Hospital of Anyang known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #15,576 of 17,978 | 2.6% | 404 | |
| Health SciencesDomain | #18,202 of 20,462 | 2.7% | 425 |
Each strip is that field’s whole ranked pool, with the notch where The Fifth People's Hospital of Anyang sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.
- Medicine 3.5×
- Dentistry 2.5×
- Immunology and Microbiology 2.4×
- Biochemistry, Genetics and Molecular Biology 2.1×
- Neuroscience 1.5×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Materials Science 1.1×
- Nursing 1.0×
- Health Professions 0.8×
- Psychology 0.5×
- Decision Sciences 0.3×
- Engineering 0.2×
- Environmental Science 0.2×
- Chemistry 0.1×
- Computer Science 0.1×
- Energy 0.1×
- Economics, Econometrics and Finance 0.1×
- Agricultural and Biological Sciences 0.1×
- Physics and Astronomy 0.0×
- Social Sciences 0.0×
Which keywords describe research at The Fifth People's Hospital of Anyang?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Cancer, Inflammation, Chemotherapy, Cancer Therapy, Tumor Microenvironment, Clinical Practice Guidelines and Immune Response.
- Survival Analysis
- Gastric Cancer
- Surgery
- Mutation
- Endothelial Dysfunction
- Tumor Targeting
- Pathophysiology
- Metastasis
- SARS-CoV-2
- Gene Expression
- ACE2 Receptor
- Tumor Microenvironment
- Clinical Practice Guidelines
- Biomedical Applications
- Immune Response
- Nanoparticles
- Cancer Therapy
- Quality of Life
- Oxidative Stress
- Cancer
- Epidemiology
- Inflammation
- Chemotherapy
- Treatment
- Management
- Diagnosis
- Meta-Analysis
- Cardiovascular Disease
- Immunotherapy
- Angiogenesis
- Biomarkers
- Neoadjuvant Therapy
- Endoscopic Resection
- Neuroinflammation
- Prognostic Factors
- Vaccine
- Neuroprotection
- Radiotherapy
- Cognitive Impairment
- Ischemic Stroke
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology6▲ 2.8×39 topics
- Cancer4▲ 5.4×25 topics
- Inflammation4▲ 3.5×31 topics
- Oxidative Stress3▲ 2.8×18 topics
- Chemotherapy2▲ 6.2×10 topics
- Quality of Life2▲ 2.7×13 topics
- Treatment2▲ 3.1×15 topics
- Cancer Therapy2▲ 6.1×8 topics
- Management2▲ 4.5×11 topics
- Nanoparticles2▲ 2.9×7 topics
- Diagnosis2▲ 3.7×13 topics
- Immune Response2▲ 5.8×7 topics
- Meta-Analysis2▲ 5.6×8 topics
- Biomedical Applications2▲ 2.8×5 topics
- Cardiovascular Disease2▲ 2.9×13 topics
- Clinical Practice Guidelines2▲ 6.0×9 topics
- Immunotherapy2▲ 4.4×7 topics
- Tumor Microenvironment2▲ 7.3×7 topics
- Angiogenesis2▲ 8.8×8 topics
- ACE2 Receptor2▲ 11×3 topics
- Biomarkers2▲ 4.0×8 topics
- Gene Expression2▲ 4.3×8 topics
- Neoadjuvant Therapy2▲ 11×3 topics
- SARS-CoV-22▲ 8.2×3 topics
- Endoscopic Resection1▲ 25×2 topics
- Metastasis1▲ 7.4×6 topics
- Neuroinflammation1▲ 8.9×6 topics
- Pathophysiology1▲ 8.3×5 topics
- Prognostic Factors1▲ 5.7×6 topics
- Tumor Targeting1▲ 14×3 topics
- Vaccine1▲ 6.2×7 topics
- Endothelial Dysfunction1▲ 10×4 topics
- Neuroprotection1▲ 6.7×6 topics
- Mutation1▲ 11×2 topics
- Radiotherapy1▲ 5.6×6 topics
- Surgery1▲ 6.1×4 topics
- Cognitive Impairment1▲ 7.6×3 topics
- Gastric Cancer1▲ 17×3 topics
- Ischemic Stroke1▲ 13×3 topics
- Survival Analysis1▲ 7.4×5 topics
Which research topics does The Fifth People's Hospital of Anyang publish most on?
By volume in 2022–2025: Esophageal Cancer Research and Treatment, Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics and Folate and B Vitamins Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Esophageal Cancer Research and Treatment Surgery 1 works
- 2 Nanoparticle-Based Drug Delivery Biomaterials 1 works
- 3 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
- 4 Folate and B Vitamins Research Rheumatology 1 works
- 5 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 6 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
- 7 Acute Ischemic Stroke Management Epidemiology 1 works
- 8 Acute Myeloid Leukemia Research Hematology 1 works
- 9 Cerebrovascular and Carotid Artery Diseases Pulmonary and Respiratory Medicine 0 works
- 10 Cancer-related molecular mechanisms research Cancer Research 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has The Fifth People's Hospital of Anyang's research output changed?
Output in 2018–2022 was 62% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.